13D/13G Filings - NEKTAR THERAPEUTICS (NKTR)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-10
11:28 am
Purchase
2020-12-31 13G Nektar Therapeutics
NKTR
The Vanguard Group 1,084,839
9.070%
7,665increase
(+0.71%)
Filing
History
2021-02-08
10:29 am
Purchase
2021-02-05 13G Nektar Therapeutics
NKTR
FMR LLC 1,263,312
10.562%
16,752increase
(+1.34%)
Filing
History
2021-02-04
11:31 am
Sale
2020-12-31 13G Nektar Therapeutics
NKTR
Wellington Management Group LLP 892,841
7.470%
-187,038decrease
(-17.32%)
Filing
History
2021-01-26
6:52 pm
Sale
2020-12-31 13G Nektar Therapeutics
NKTR
BlackRock Inc.
BLK
1,225,205
10.200%
-2,630decrease
(-0.21%)
Filing
History
Goto Prev, 0, 1, 2